{"fieldData": {"title": "Update to the biological agents directive to include SARS-CoV-2 ", "title_nationalLanguage": "", "d_startDate": "06/03/2017", "d_endDate": "", "calc_country": "European Union", "calc_minorCategory": "Protection of workers, adaptation of workplace", "calc_subMinorCategory": "Occupational health and safety", "calc_identifier": "EU-2017-22/1092", "dateType": "Open ended", "calc_creationDay": "09/10/2020", "calc_lastUpdate": "09/23/2020", "descriptionBackgroundInfo": "On 3 June 2020, the European Commission adopted an update of the Biological Factors Directive (2000/54/EC) to include SARS-CoV-2 in the list of biological agents it covers (the Annex III to the directive was amended).\r\rThe Biological Agents Directive is the seventh individual directive within the meaning of Article 16(1) of Directive 89/391/EEC. For the purpose of this Directive: _'biological agents'_ shall mean micro-organisms, including those which have been genetically modified, cell cultures and human endoparasites, which may be able to provoke any infection, allergy or toxicity. According to the Directive employers must keep abreast of new developments in technology with a view to improving the protection of workers' health and safety.", "descriptionContentOfMeasure": "According to unanimously recommendation of experts from all Member States the coronavirus SARS-CoV-2 was classified in group 3 of biological agents. Such classification means an obligation for increased protection for workers in labs, industrial processes and isolation facilities in health care in any coronavirus threat situation.\rThe following criteria were considered relevant in relation to SARS-CoV-2:\r\r* it can cause severe human disease and present a serious hazard to workers;\r* it may present a risk of spreading to the community;\r* there is usually effective prophylaxis available.\r\rMember States shall bring into force the laws, regulations and administrative provisions necessary to comply with this Directive by 24 November 2020 at the latest.\r", "descriptionUseOfMeasure": "All employees in the EU.", "descriptionInvolvementOfSocialPartners": "Social partners were  involved in the process of designing through the tripartite Advisory Committee on Health and Safety at Work.", "socialPartner_form": "", "socialPartner_role": "", "calc_githubURL": "https://static.eurofound.europa.eu/covid19db/cases/EU-2017-22_1092.html", "isOccupation": "No", "isSector": "No", "sector_privateOrPublic": "Not specified", "calc_type": "Legislations or other statutory regulations", "statusOfRegulation": "New aspects included into existing measure"}, "portalData": {"sources": [{"recordId": "1398", "sources::title": "COMMISSION DIRECTIVE (EU) 2020/739\rof 3 June 2020\ramending Annex III to Directive 2000/54/EC of the European Parliament and of the Council as\rregards the inclusion of SARS-CoV-2 in the list of biological agents known to infect humans and\ramending Commission Directive (EU) 2019/1833", "sources::url": "https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32020L0739&from=EN", "sources::d_date": "06/03/2020", "modId": "0", "downloaded_to": "96408587b2c6a6f6e2e350c85f8bfb0df54057794099cad53991f4ac6bc9fb53"}], "actors": [{"recordId": "10", "actors::name": "EU (Council, EC, EP)", "modId": "0"}], "targetGroups": [], "funding": [{"recordId": "12", "funding::name": "No special funding required", "modId": "0"}], "occupations": [], "sectors": [], "updates": [], "regions": []}, "recordId": "1002", "modId": "20"}